Integration of Custom Media into the Marketing Mix
This article summarizes a discussion with Abraham Ogden, the Director of Book Publications for the American Diabetes Association, about integrating ADA's custom publications into the pharma marketing mix.
Pharma Marketing News Vol. 9, #8: October 2010
Welcome to the October 2010 issue of Pharma Marketing News. This is the Executive Summary. This executive summary includes links to ALL the OCTOBER 2010 articles.
Pharma Marketing News Vol. 9, #8: October 2010
Welcome to the October 2010 issue of Pharma Marketing News. This is the Executive Summary. This executive summary includes links to ALL the OCTOBER 2010 articles.
I am Off to London to Meet Some EU ePharma Pioneers at the DigiPharm...
I leave tonight to attend and speak at the 2nd annual DigiPharm Europe 2010 conference in London. I am looking forward to meeting a...
Avandia and Janet Woodcock, the Next FDA Commissioner
By now you all know about FDA's decision to put restrictions on how physicians prescribe Avandia in the US (see "FDA will significantly restrict...
Did J&J Troll Social Media Sites to Ensure Its Motrin “Recall” was a Secret?
A Blog is a very useful archive of information that over time may reveal connections between seemingly unrelated events. Take the Johnson and Johnson...
LillyPad Launches Specious Rocket Attack Against Drug Price Control Straw Man
Eli Lilly, the drug company that increased the price of its antidepressant Cymbalta by 13.6% in 2009, is using its new corporate blog (LillyPad)...
Are Secret Drug Recalls Common?
When Johnson and Johnson's McNeil Pharmaceuticals discovered that Motrin tablets on drugstore shelves might be faulty, the company hired contractors to purchase all the...
Online Behavioral Tracking Becomes More Sophisticated, Annoying — Soon Illegal?
A few months ago, I searched for and bought a futon on Overstock.com. For weeks afterward I kept seeing ads for Overstock.com futons pop...
J&J’s Goggins Takes Bullet for CEO Weldon
The New York Times reports that Colleen A. Goggins, who testified this spring before a Congressional committee investigating the recalls, will retire in March....
